A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: P51 OD011106
NIAID NIH HHS
Grant: R37 AI091476
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201700003C, R00AI138860 , R01AI167724 , R01AI116698
NIAID NIH HHS
Grant: R00 AI138860
NIAID NIH HHS
Grant: HHSN272201700003C
NIAID NIH HHS
Grant: R01 AI116698
NIAID NIH HHS
Grant: R01 AI167724
National Institutes of Health
Grant: 5R01AI167724-02
Optimizing AAV delivery of bNAbs for HIV prevention
National Institutes of Health
Grant: 2R01AI116698-06
AAV capsid engineering for enhancing gene transfer
National Institutes of Health
Grant: 4R00AI138860-03
AAV-Delivered Broadly Neutralizing Antibodies for HIV Suppression
Fields of Study
MeSH Terms
Keywords